3B Blackbio [3BBLACKBIO] vs Biocon [BIOCON] Detailed Stock Comparison
3B Blackbio
BSE
Loading...
Biocon
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: 3B Blackbio wins in 10 metrics, Biocon wins in 9 metrics, with 0 ties. 3B Blackbio appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | 3B Blackbio | Biocon | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 24.99 | 113.56 | 3B Blackbio |
| Price-to-Book Ratio | 4.79 | 2.01 | Biocon |
| Debt-to-Equity Ratio | 0.11 | 66.26 | 3B Blackbio |
| PEG Ratio | 1.90 | -1.19 | Biocon |
| EV/EBITDA | 24.19 | 19.66 | Biocon |
| Profit Margin (TTM) | 49.51% | 2.44% | 3B Blackbio |
| Operating Margin (TTM) | 51.98% | 7.46% | 3B Blackbio |
| EBITDA Margin (TTM) | 51.98% | 7.46% | 3B Blackbio |
| Return on Equity | 17.58% | 3.66% | 3B Blackbio |
| Return on Assets (TTM) | 16.11% | 1.72% | 3B Blackbio |
| Free Cash Flow (TTM) | $424.53M | $17.18B | Biocon |
| Dividend Yield | N/A | 0.26% | N/A |
| 1-Year Return | -1.28% | -3.81% | 3B Blackbio |
| Price-to-Sales Ratio (TTM) | 12.41 | 3.08 | Biocon |
| Enterprise Value | $12.34B | $634.39B | Biocon |
| EV/Revenue Ratio | 12.43 | 4.02 | Biocon |
| Gross Profit Margin (TTM) | 75.00% | 64.06% | 3B Blackbio |
| Revenue per Share (TTM) | $116 | $131 | Biocon |
| Earnings per Share (Diluted) | $57.42 | $3.20 | 3B Blackbio |
| Beta (Stock Volatility) | 0.28 | 0.23 | Biocon |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
3B Blackbio vs Biocon Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| 3B Blackbio | -0.62% | -0.38% | -7.15% | -12.37% | -23.31% | -26.79% |
| Biocon | -0.08% | 2.36% | 6.55% | 7.79% | 11.08% | -1.17% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| 3B Blackbio | -1.28% | 81.34% | 81.34% | 81.34% | 81.34% | 81.34% |
| Biocon | -3.81% | 25.15% | -19.71% | 396.12% | 518.11% | 793.82% |
News Based Sentiment: 3B Blackbio vs Biocon
3B Blackbio
News based Sentiment: NEUTRAL
The month was largely focused on routine corporate governance activities – the AGM and dividend distribution – with moderate share price movements. While positive for shareholder engagement, these events don't represent a significant shift in the company's overall investment story, making it a relatively neutral month.
Biocon
News based Sentiment: MIXED
September presented a mixed bag for Biocon, with a significant profit decline offset by a major investment and generally positive analyst outlook. The FDA inspection, while requiring a CAPA plan, didn't appear to pose a major threat, creating a complex investment narrative.
Performance & Financial Health Analysis: 3B Blackbio vs Biocon
| Metric | 3BBLACKBIO | BIOCON |
|---|---|---|
| Market Information | ||
| Market Cap | ₹12.10B | ₹485.52B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 9,668 | 2,035,256 |
| 90 Day Avg. Volume | 9,151 | 3,068,471 |
| Last Close | ₹1,410.35 | ₹364.20 |
| 52 Week Range | ₹1,349.95 - ₹2,205.00 | ₹291.00 - ₹406.00 |
| % from 52W High | -36.04% | -10.30% |
| All-Time High | ₹2,350.00 (Dec 09, 2024) | ₹487.75 (Dec 21, 2020) |
| % from All-Time High | -39.99% | -25.33% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.14% | 0.15% |
| Quarterly Earnings Growth | 0.13% | -0.95% |
| Financial Health | ||
| Profit Margin (TTM) | 0.50% | 0.02% |
| Operating Margin (TTM) | 0.52% | 0.07% |
| Return on Equity (TTM) | 0.18% | 0.04% |
| Debt to Equity (MRQ) | 0.11 | 66.26 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹299.81 | ₹180.66 |
| Cash per Share (MRQ) | ₹14.62 | ₹38.10 |
| Operating Cash Flow (TTM) | ₹619.97M | ₹17.78B |
| Levered Free Cash Flow (TTM) | ₹476.52M | ₹10.13B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.26% |
| Last 12-Month Dividend | N/A | ₹1.00 |
Valuation & Enterprise Metrics Analysis: 3B Blackbio vs Biocon
| Metric | 3BBLACKBIO | BIOCON |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 24.99 | 113.56 |
| Forward P/E | N/A | 36.63 |
| PEG Ratio | 1.90 | -1.19 |
| Price to Sales (TTM) | 12.41 | 3.08 |
| Price to Book (MRQ) | 4.79 | 2.01 |
| Market Capitalization | ||
| Market Capitalization | ₹12.10B | ₹485.52B |
| Enterprise Value | ₹12.34B | ₹634.39B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 12.43 | 4.02 |
| Enterprise to EBITDA | 24.19 | 19.66 |
| Risk & Other Metrics | ||
| Beta | 0.28 | 0.23 |
| Book Value per Share (MRQ) | ₹299.81 | ₹180.66 |
Financial Statements Comparison: 3B Blackbio vs Biocon
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | 3BBLACKBIO | BIOCON |
|---|---|---|
| Revenue/Sales | ₹222.35M | ₹39.10B |
| Cost of Goods Sold | ₹55.60M | ₹14.05B |
| Gross Profit | ₹166.75M | ₹25.05B |
| Research & Development | N/A | ₹-346.00M |
| Operating Income (EBIT) | ₹115.57M | ₹2.94B |
| EBITDA | ₹161.51M | ₹8.29B |
| Pre-Tax Income | ₹158.64M | ₹969.00M |
| Income Tax | ₹32.19M | ₹77.00M |
| Net Income (Profit) | ₹126.45M | ₹892.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | 3BBLACKBIO | BIOCON |
|---|---|---|
| Cash & Equivalents | ₹124.73M | ₹32.27B |
| Total Current Assets | ₹1.32B | ₹162.86B |
| Total Current Liabilities | ₹185.88M | ₹143.34B |
| Long-Term Debt | ₹3.07M | ₹129.45B |
| Total Shareholders Equity | ₹2.71B | ₹277.13B |
| Retained Earnings | N/A | ₹189.59B |
| Property, Plant & Equipment | ₹72.19M | ₹4.32B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | 3BBLACKBIO | BIOCON |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | 3BBLACKBIO | BIOCON |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 9,668 | 2,035,256 |
| Average Daily Volume (90 Day) | 9,151 | 3,068,471 |
| Shares Outstanding | 8.58M | 1.20B |
| Float Shares | 2.62M | 523.92M |
| % Held by Insiders | 0.69% | 0.56% |
| % Held by Institutions | 0.02% | 0.24% |
Dividend Analysis & Yield Comparison: 3B Blackbio vs Biocon
| Metric | 3BBLACKBIO | BIOCON |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹1.00 |
| Last 12-Month Dividend Yield | N/A | 0.26% |
| 3-Year Avg Annual Dividend | N/A | ₹1.33 |
| 3-Year Avg Dividend Yield | N/A | 0.36% |
| 3-Year Total Dividends | N/A | ₹4.00 |
| Ex-Dividend Date | N/A | Jul 04, 2025 |